KAŠPÁRKOVÁ, Jana, Olga NOVAKOVÁ, María Victoria MARINI PALOMEQUE, Yousef NAJAJREH, Dan GIBSON, Jose-Manuel PEREZ a Viktor BRABEC. Activation of trans geometry in bifunctional mononuclear platinum complexes by a piperidine ligand. Mechanistic studies on antitumor action. Journal of Biological Chemistry. Bethesda, USA: Amer. Soc. Biochem. Mol. Biol., 2003, roč. 278, č. 48, s. 47516-47525. ISSN 0021-9258.
Další formáty:   BibTeX LaTeX RIS
Základní údaje
Originální název Activation of trans geometry in bifunctional mononuclear platinum complexes by a piperidine ligand. Mechanistic studies on antitumor action
Název česky Aktivace trans geometrie bifunkcnich mononuklearnich platinovych komplexu piperidinovym ligandem.
Autoři KAŠPÁRKOVÁ, Jana (203 Česká republika), Olga NOVAKOVÁ (203 Česká republika), María Victoria MARINI PALOMEQUE (858 Uruguay), Yousef NAJAJREH (275 Palestina), Dan GIBSON (376 Izrael), Jose-Manuel PEREZ (724 Španělsko) a Viktor BRABEC (203 Česká republika, garant).
Vydání Journal of Biological Chemistry, Bethesda, USA, Amer. Soc. Biochem. Mol. Biol. 2003, 0021-9258.
Další údaje
Originální jazyk angličtina
Typ výsledku Článek v odborném periodiku
Obor 10610 Biophysics
Stát vydavatele Spojené státy
Utajení není předmětem státního či obchodního tajemství
Impakt faktor Impact factor: 6.482
Kód RIV RIV/00216224:14310/03:00029122
Organizační jednotka Přírodovědecká fakulta
Klíčová slova anglicky cisplatin; platinum complexes; DNA; antitumor
Štítky antitumor, cisplatin, DNA, platinum complexes
Změnil Změnila: Mgr. María Victoria Marini Palomeque, Ph.D., učo 22912. Změněno: 15. 11. 2008 17:39.
Anotace
A paradigm for the structure-pharmacological activity relationship of bifunctional platinum antitumor drugs is that the trans isomer of antitumor cisplatin (transplatin) is clinically ineffective. To this end, however, several new complexes of the trans structure have been identified that exhibit cytotoxicity in tumor cells that is even better than that of the analogous cis isomers. We reported recently (Kasparkova, J., Marini, V., Najajreh, Y., Gibson, D., and Brabec, V. (2003) Biochemistry 42, 6321-6332) that the replacement of one ammine ligand by the heterocyclic ligand, such as piperidine, piperazine, or 4-picoline in the molecule of transplatin resulted in a radical enhancement of its cytotoxicity. We examined oligodeoxyribonucleotide duplexes bearing a site-specific cross-link of the transplatin analogue containing the piperidine ligand by biochemical methods. The results indicate that in contrast to transplatin, trans-(PtCl2(NH3)(piperidine)) forms stable 1,3-intrastrand cross-links in double-helical DNA that distort DNA and are not readily removed from DNA by nucleotide excision repair system. Hence, the intrastrand cross-links of trans-(PtCl2(NH3)(piperidine)) could persist for a sufficiently long time, potentiating its toxicity toward tumor cells. trans-(PtCl2(NH3)(piperidine)) also forms in DNA minor interstrand cross-links that are similar to those of transplatin so that these adducts appear less likely candidates for genotoxic lesion responsible for antitumor effects of trans-(PtCl2(NH3)(piperidine)). Hence, the role of structurally unique intrastrand cross-links in the anti-tumor effects of transplatin analogues in which one ammine group is replaced by a heterocyclic ligand may predominate.
Anotace česky
cz
Návaznosti
GA305/02/1552, projekt VaVNázev: Oligonukleotidy modifikované komplexy platiny pro selektivní modulaci genové exprese; vztah k "protismyslné" strategii při vývoji nových farmak.
VytisknoutZobrazeno: 25. 4. 2024 04:05